June 2, 2020, 5:28 pm EDT
2020 Actual Trade MRNA +74% Profit
- In early March, US and Europe became epic center for the virus with pandemic status
- Moderna was the first company with vaccines for trail for COVD-19 virus
- Break through technology and fast turn around made Moderna a winner so added MRNA to portfolio
- Positive Phase I result was announced on May that created a gap-up climax run
- Closed and took +74% in roughly 3 months holding
